<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01455077</url>
  </required_header>
  <id_info>
    <org_study_id>CEP0290/11</org_study_id>
    <secondary_id>Portable monitoring system for</secondary_id>
    <secondary_id>STD obesity</secondary_id>
    <nct_id>NCT01455077</nct_id>
  </id_info>
  <brief_title>Portable Monitoring Device for the Diagnosis of Sleep Apnea in Obese Patients</brief_title>
  <official_title>Validation of a Portable Monitoring System for the Diagnosis of Obstructive Sleep Apnea Syndrome in Patients With Level II and III Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Associacao Fundo de Incentivo a Psicofarmcologia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Associacao Fundo de Incentivo a Psicofarmcologia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction The portable monitoring system (PMS) recording of cardiopulmonary parameters
      (level III of ASDA) has been validated in subjects with high probability of Obstructive Sleep
      Apnea (OSA) without comorbidities.

      However, there is not any study evaluating this system when OSA is associated with morbid
      obesity, so the validation of PMS will be very useful in order to properly work-up this
      highly risk population.

      Objective:

      To evaluate the accuracy of level III type of PMS - Stardust™&quot; (STD), on patients with level
      II and III of obesity and high clinical suspicion of OSA.

      Methods:Participants with BMI &gt; 35 kg/m2 and with suspicion of OSA will consecutively be
      selected from an Outpatients Sleep Clinic of UNIFESP. They will be randomized for the
      following order of recordings:

      1) STD at home for 1 night 2) STD in the sleep lab simultaneous to PSG. AHI will be taken for
      subsequent analysis:a) AHI PSG b) AHI STD -lab and c) AHI STD- home.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">January 2012</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Obstructive Sleep Apnea Syndrome</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Obese patients</arm_group_label>
    <description>BMI &gt; 35</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adults BMI &gt; 35 Male and female
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &gt; 35

          -  Complaints of snoring, sleep apnea, daytime sleepiness

        Exclusion Criteria:

          -  use of home oxygen

          -  other sleep diseases

          -  inability to perform PSG
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lia R Bittencourt, MD, PhD</last_name>
    <phone>55 11 21490155</phone>
    <email>lia@psicobio.epm.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Associacao Fundo de Incentivo a Psicofarmacologia</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lia R Bittencourt, MD, PhD</last_name>
      <phone>55 11 21490155</phone>
      <email>lia@psicobio.epm.br</email>
    </contact>
    <contact_backup>
      <last_name>Erika C Treptow</last_name>
      <email>erikatpw@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Erika C Treptow</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 15, 2011</study_first_submitted>
  <study_first_submitted_qc>October 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2011</study_first_posted>
  <last_update_submitted>October 18, 2011</last_update_submitted>
  <last_update_submitted_qc>October 18, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 19, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Associacao Fundo de Incentivo a Psicofarmcologia</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Lia Azeredo-Bittencourt</investigator_full_name>
    <investigator_title>MD, PhD, associate professor</investigator_title>
  </responsible_party>
  <keyword>obesity</keyword>
  <keyword>sleep apnea</keyword>
  <keyword>portable monitoring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

